Q&M Dental Group

Covid-19

Q&M eyes joint venture with 2 China companies to manufacture surgical masks

The Covid-19 outbreak has led to a surge in prices for surgical masks, on the back of a worldwide shortage in supply.

Covid-19

Q&M reports 3 patients with suspected coronavirus infection at City Square Mall, Tampines 1 Mall clinics

Q&M says it has not yet been informed by MOH on the outcome of the tests.

Healthcare

Q&M opens private dentistry college in Singapore; aims to produce 'Super GPs'

SINGAPORE (Oct 17): Q&M Dental Group on Thursday opened Singapore’s first private dentistry college offering graduate diploma studies in clinical dentistry.

Results

Q&M Dental posts 4% rise in 2Q earnings to $4.8 mil

SINGAPORE (Aug 14): Q&M Dental Group saw its earnings grow 4% to $4.8 million for the 2Q19 ended June, from $4.6 million a year ago.

Deals, joint ventures & alliances

Q&M collaborates with IMU Education to develop AI-enhanced system

SINGAPORE (April 9): Q&M Dental Group is partnering Malaysian private university operator IMU Education Sdn Bhd to develop an artificial intelligence (AI) enhanced dental treatment decision support system to manage common dental problems.

Results

Q&M posts 40% drop in FY18 earnings on absence of one-off gain on disposal

SINGAPORE (Feb 28): Q&M Dental Group saw its earnings fall 40% to $14.3 million for the FY18 ended December, from $23.9 million a year ago.

Results

Q&M reports 67% drop in 2Q earnings to $4.6 mil on absence of one-off gain

SINGAPORE (Aug 14): Q&M Dental Group posted earnings of $4.6 million for the 2Q ended June, some 67% lower than earnings of $13.6 million a year ago.

Broker's Calls

No smiles yet for Q&M Dental

SINGAPORE (May 16): Phillip Capital is keeping its “neutral” rating on Q&M Dental Group with an unchanged target price of 63 cents, despite the group reporting a set of “encouraging results” in 1Q18.

Broker's Calls

Q&M still lacks bite, says CIMB

SINGAPORE (Jan 8): CIMB Research is keeping its “reduce” rating on Q&M Dental Group with a marginally higher target price of 61 cents, up from 60 cents previously, even as the private dental healthcare provider looks likely to continue its pursuit of
×